Vanguard FTSE Developed Europe All Cap Index ETF (TSX:VE)
Assets | 282.74M |
Expense Ratio | 0.23% |
PE Ratio | 16.02 |
Dividend (ttm) | 1.10 |
Dividend Yield | 2.95% |
Ex-Dividend Date | Mar 21, 2025 |
Payout Frequency | Quarterly |
Payout Ratio | 43.11% |
1-Year Return | +12.38% |
Volume | 42,974 |
Open | 37.69 |
Previous Close | 37.44 |
Day's Range | 37.60 - 37.95 |
52-Week Low | 34.20 |
52-Week High | 41.07 |
Beta | 1.00 |
Holdings | 1232 |
Inception Date | Jun 30, 2014 |
About VE
Vanguard FTSE Developed Europe All Cap Index ETF is an exchange traded fund launched and managed by Vanguard Investments Canada Inc. The fund is co-managed by Vanguard Global Advisers, LLC. The fund invests in public equity markets of European Developed region. The fund invests in stocks of companies operating across diversified sectors. It invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the FTSE Developed Europe All Cap Index, by using full replication technique. Vanguard FTSE Developed Europe All Cap Index ETF was formed on June 30, 2014 and is domiciled in Canada.
Performance
VE had a total return of 12.38% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.02%.
Top 10 Holdings
17.95% of assetsName | Symbol | Weight |
---|---|---|
SAP SE | SAP | 2.29% |
Nestlé S.A. | NESN | 2.05% |
ASML Holding N.V. | ASML | 2.00% |
Roche Holding AG | ROG | 1.77% |
Shell plc | SHEL | 1.75% |
Novartis AG | NOVN | 1.72% |
Novo Nordisk A/S | NOVO.B | 1.72% |
AstraZeneca PLC | AZN | 1.72% |
HSBC Holdings plc | HSBA | 1.59% |
Siemens Aktiengesellschaft | SIE | 1.34% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Mar 21, 2025 | 0.13585 CAD | Mar 28, 2025 |
Dec 30, 2024 | 0.15485 CAD | Jan 7, 2025 |
Sep 20, 2024 | 0.13568 CAD | Sep 27, 2024 |
Jun 21, 2024 | 0.66965 CAD | Jun 28, 2024 |
Mar 15, 2024 | 0.09295 CAD | Mar 25, 2024 |
Dec 28, 2023 | 0.1771 CAD | Jan 8, 2024 |